PharmaBoardroom

Let’s start by introducing our readers to the Austrian affiliate of Cegedim. Can you summarize Cegedim scope of activities and operations in…

In your opinion, what have been the most important developments of the healthcare market in Austria over the last three years? To start with, even…

Mr. Cooke, you joined Alkermes after the company acquired the Elan Drug Technologies (EDT) unit in 2011—a unit you headed for four years. Can…

Mr. Somers, can you please introduce us to the Helsinn Group and its unique in-licensing model? Helsinn is a Swiss-based, private company owned by…

Can you give a brief summary of how Intercell started, how it developed and where it stands today? Intercell was created in 1997 as a spinoff from…

Mylan embarked upon its first major international expansion program in 2007, after the acquisition of Merck KGaA’s generic medicines business.…

In three months you will be celebrating two years as the head of Takeda Colombia. Your two major objectives were to set up the Andean cluster…

Mr. Keogh, you founded Millmount Healthcare in 1999. What was the vision behind the company? Prior to founding Millmount, I spent ten years in…

A list of the top ten distributors in Russia's pharmaceutical sector between Q1 and Q3 2011.

One of NNE Pharmaplan’s latest exciting news is that last year you established offices to accommodate your existing customers in Belgium. What…

You have been with Grünenthal since 2004 and as the Austria Country Manager since June 2012. What were your initial goals when you took up the…

Can you give our readers a snapshot of the scope of Takeda’s operations and the organizational structure within Austria? Takeda in Austria is a…